Journal
THORAX
Volume 62, Issue 4, Pages 360-367Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/thx.2006.060889
Keywords
-
Categories
Funding
- NHLBI NIH HHS [K23 HL072017, 1 K23 HL72017-01] Funding Source: Medline
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL072017] Funding Source: NIH RePORTER
Ask authors/readers for more resources
With the improving survival of patients with cystic fibrosis (CF), the clinical spectrum of this complex multisystem disease continues to evolve. One of the most important clinical events for patients with CF in the course of this disease is an acute pulmonary exacerbation. Clinical and microbial epidemiology studies of CF pulmonary exacerbations continue to provide important insight into the course, prognosis and complications of the disease. This review provides a summary of the pathophysiology, clinical epidemiology and microbial epidemiology of a CF pulmonary exacerbation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available